New Joint CEO for Cello Firm Insight Health US

New York-based Insight Health US, a part of the Cello Group, has hired former Hall & Partners leader Kathryn Gallant as joint CEO. She replaces Avanti Ananthram who moves to the London HQ of parent company Insight Research Group, for the new role of Head of International Development.

Jessica Cunningham remains in the other Joint CEO role at the US firm.

As managing partner for US health at Hall & Partners, Gallant managed a broad portfolio of global pharmaceutical clients and a large full service research team across North America. She spent just eight years at the firm, joining from Strategic Marketing Corporation (now part of GfK) where she was a Director. Her total of fourteen years of MR experience spans both global and US domestic healthcare research, with a particular interest in the development of new research tools for qual, quant and anthropological research.

Jane Shirley, CEO of Insight Research Group, comments: 'We are delighted that Kathryn will be joining us to help drive the next stage of Insight's growth in the US.' The group says Ananthram 'will continue to play a pivotal role in the on-going success of Insight Health US'.

Insight Research Group turned over £20m in 2012 and employs around 120 people. The US subsidiary is online at www.insighthealthus.com .